Heilmittelchemische Studien In Der Heterocyclischen Reihe 36. Mitteilung. Über Sydnonimine. II. Herstellung und Eigenschaften von Sydnoniminen mit Acyl-, Carbamoyl- und Thiocarbamoyl-Substituenten am exocyclischen Stickstoffatom
作者:H. U. Daeniker、J. Druey
DOI:10.1002/hlca.19620450714
日期:——
substituted on the exocyclic nitrogen atom by acyl, carbamoyl and thiocarbamoyl is described. Unexpectedly, all these derivatives are bases and form salts with acids. The physico-chemical properties of these compounds have been studied, especially in view of their basic properties. The chemical behaviourtowards acids, bases and catalytic hydrogenation has been investigated. An interesting rearrangement
recently discovered a novel reaction between iminosydnones and strained alkynes leading to two products resulting from ligation and fragmentation of iminosydnones under physiological conditions. We now report the synthesis of a panel of substituted iminosydnones and the structure reactivity relationship between these compounds and strained alkyne partners. This study identified the most relevant substituents
Iminosydnone derivatives for conjugation and release of compounds of interest
申请人:L'Universite de Strasbourg
公开号:EP2957559A1
公开(公告)日:2015-12-23
The present invention relates to the use of iminosydnone compounds in processes for the preparation of conjugates of two compounds of interest. The invention further relates to the use of said iminosydnone compounds in a process for releasing a third compound of interest. The invention finally relates to said new iminosydnone compounds.
[EN] USE OF SYDNONIMINES TO TREAT ERECTILE DYSFUNCTION
申请人:CASSELLA AKTIENGESELLSCHAFT
公开号:WO1993018767A1
公开(公告)日:1993-09-30
(DE) Die vorliegende Erfindung betrifft die Verwendung von Sydnoniminen der allgemeinen Formel (I) gemäß Hauptanspruch sowie pharmakologisch verträgliche Salze davon zur Behandlung erektiler Dysfunktionen.(EN) The present invention concerns the use of sydnonimines of general formula (I) as disclosed in the main claim, as well as pharmacologically non-toxic salts thereof, for treating erectile dysfunction.(FR) L'invention concerne l'utilisation de sydnonimines de la formule générale (I) selon la revendication principale, ainsi que de leurs sels compatibles sur le plan pharmacologique, pour traiter les troubles de l'érection.